Asn25 Deamidation as an Allosteric Tool to Increase IFNβ-1a Biological Activity

Area of Science:

• Immunology
• Molecular Biology
• Biochemistry

Background:

• Interferon beta (IFNβ) is a type I cytokine with antiviral, immunomodulatory, and antiproliferative functions.
• Previous studies indicated that artificially deamidated IFNβ-1a at Asn25 exhibits enhanced biological activity.

Purpose of the Study:

• To elucidate the molecular mechanism behind the increased biological activity of deamidated IFNβ-1a.
• To compare the receptor binding and canonical pathway activation of deamidated IFNβ-1a with the native form.

Main Methods:

• Experimental and computational techniques were employed.
• Molecular dynamics simulations were performed to analyze receptor interactions.
• STAT1 phosphorylation and interferon-stimulated gene expression were measured.

Main Results:

• Deamidated IFNβ-1a demonstrated altered receptor affinity compared to native IFNβ-1a.
• The N25D mutation enhanced binding to the IFNAR1 receptor by involving additional residues.
• Increased STAT1 phosphorylation and interferon-stimulated gene expression were observed.

Conclusions:

• The study deciphers the molecular mechanism of deamidated IFNβ-1a's enhanced activity.
• The findings reveal improved binding to IFNAR1, leading to a stronger signaling cascade.
• This research opens avenues for novel therapeutic strategies utilizing modified IFNβ-1a.